AAMT, D., K, v. d. Z., CMA, R., TCG, E., REG, S., & K, F. (2023). The efficacy of the entire-vial dosing of emicizumab: Real-world evidence on plasma concentrations, bleeds, and drug waste. Research and practice in thrombosis and haemostasis, 7(2), 100074. https://doi.org/10.1016/j.rpth.2023.100074
Chicago Style (17th ed.) CitationAAMT, Donners, van der Zwet K, Rademaker CMA, Egberts TCG, Schutgens REG, and Fischer K. "The Efficacy of the Entire-vial Dosing of Emicizumab: Real-world Evidence on Plasma Concentrations, Bleeds, and Drug Waste." Research and Practice in Thrombosis and Haemostasis 7, no. 2 (2023): 100074. https://doi.org/10.1016/j.rpth.2023.100074.
MLA (9th ed.) CitationAAMT, Donners, et al. "The Efficacy of the Entire-vial Dosing of Emicizumab: Real-world Evidence on Plasma Concentrations, Bleeds, and Drug Waste." Research and Practice in Thrombosis and Haemostasis, vol. 7, no. 2, 2023, p. 100074, https://doi.org/10.1016/j.rpth.2023.100074.